Thalidomide: A Banned Drug Resurged into Future Anticancer Drug-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Thalidomide: A Banned Drug Resurged into Future Anticancer Drug

Published:2012-04-01 Issue:1 Volume:7 Page:13-23
ISSN:1574-8855
Container-title:Current Drug Therapy
language:en
Short-container-title:CDTH

Author:

Ali Imran,A. Wani Waseem,Saleem Kishwar,Haque Ashanul

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spatial transcriptomics reveals tumor-derived SPP1 induces fibroblast chemotaxis and activation in the hepatocellular carcinoma microenvironment;Journal of Translational Medicine;2024-09-12

2. The expansion of MDSCs induced by exosomal PD-L1 promotes the progression of gastric cancer;Journal of Translational Medicine;2024-09-03

3. Molecular Recognition of VSIG1 in Biological Samples for Fast Diagnosis of Gastric Cancer;Journal of The Electrochemical Society;2024-07-01

4. Design, Synthesis, and Investigation of Anticancer and Antioxidant Potential of Novel Indole‐Based Melatonin Analogues in Breast Cancer;ChemistrySelect;2024-06-26

5. TCL1A-expressing B cells are critical for tertiary lymphoid structure formation and the prognosis of oral squamous cell carcinoma;Journal of Translational Medicine;2024-05-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP